Page 137 - Read Online

Chan et al. J Transl Genet Genom 2024;8:13-34 https://dx.doi.org/10.20517/jtgg.2023.36 Page 131

REFERENCES
1. Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and
projections for 2045. Diabetes Res Clin Pract 2022;183:109119. DOI
2. Xu Y, Wang L, He J, et al; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese
adults. JAMA 2013;310:948-59. DOI
3. Chan JCN, Lim LL, Wareham NJ, et al. The lancet commission on diabetes: using data to transform diabetes care and patient lives.
Lancet 2021;396:2019-82. DOI
4. Yeung RO, Zhang Y, Luk A, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE
programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014;2:935-43. DOI
5. Ke C, Stukel TA, Shah BR, et al. Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2
diabetes in Hong Kong: a population-based observational study. PLoS Med 2020;17:e1003316. DOI PubMed PMC
6. Seshasai SR, Kaptoge S, Thompson A, et al; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of
cause-specific death. N Engl J Med 2011;364:829-41. DOI PubMed PMC
7. Wu H, Lau ESH, Yang A, et al. Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney
disease: a prospective cohort study. Diabetologia 2021;64:1990-2000. DOI
8. Wu H, Yang A, Lau ESH, et al. Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: a territory-
wide population-based cohort study of 1.5 million people in Hong Kong. PLoS Med 2023;20:e1004261. DOI PubMed PMC
9. Ke C, Lau E, Shah BR, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based
cohort study. Ann Intern Med 2019;170:145-54. DOI PubMed
10. Srinivasan S, Chen L, Todd J, et al; ProDiGY Consortium. The first genome-wide association study for type 2 diabetes in youth: the
progress in diabetes genetics in youth (ProDiGY) consortium. Diabetes 2021;70:996-1005. DOI PubMed PMC
11. Zeitler P, Hirst K, Pyle L, et al; TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N
Engl J Med 2012;366:2247-56. DOI PubMed PMC
12. Ke C, Shah BR, Luk AO, Di Ruggiero E, Chan JCN. Cardiovascular outcomes trials in type 2 diabetes: time to include young adults.
Diabetes Obes Metab 2020;22:3-5. DOI PubMed
13. Magliano DJ, Chen L, Carstensen B, et al. Trends in all-cause mortality among people with diagnosed diabetes in high-income
settings: a multicountry analysis of aggregate data. Lancet Diabetes Endocrinol 2022;10:112-9. DOI
14. Magliano DJ, Islam RM, Barr ELM, et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ 2019;366:l5003.
DOI
15. Luk AOY, Ke C, Lau ESH, et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort
study. PLoS Med 2020;17:e1003052. DOI PubMed PMC
16. Wu H, Lau ESH, Ma RCW, et al. Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong,
2001-2016: a retrospective cohort study. Diabetologia 2020;63:757-66. DOI
17. Chan JCN, Lim LL, Luk AOY, et al. From Hong Kong diabetes register to JADE program to RAMP-DM for data-driven actions.
Diabetes Care 2019;42:2022-31. DOI
18. Luk A, Fan Y, Fan B, et al. 1829-PUB: precision medicine to redefine insulin secretion and monogenic diabetes randomised
controlled trial (PRISM-RCT) in Chinese patients with young-onset diabetes - study design and baseline profile. Diabetes
2023;72:1829. DOI
19. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J
Med 1988;318:1231-9. DOI
20. Gerich JE. Control of glycaemia. Baillieres Clin Endocrinol Metab 1993;7:551-86. DOI PubMed
21. Polonsky KS. The past 200 years in diabetes. N Engl J Med 2012;367:1332-40. DOI PubMed
22. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes
mellitus. Diabetes 2009;58:773-95. DOI PubMed PMC
23. McCarthy M, Zeggini E. Genetics of type 2 diabetes. Curr Rep Diabetes 2006;6:147-54. DOI PubMed
24. Fuchsberger C, Flannick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature 2016;536:41-7. DOI PubMed
PMC
25. Spracklen CN, Horikoshi M, Kim YJ, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature
2020;582:240-5. DOI
26. Ogilvie RF. A quantitative estimation of pancreatic islet tissue. QJM 1937;6:287-300. DOI
27. Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J
Clin Endocrinol Metab 2003;88:2300-8. DOI
28. Zhao HL, Lai FM, Tong PC, et al. Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2
diabetes. Diabetes 2003;52:2759-66. DOI
29. Hart PA, Bellin MD, Andersen DK, et al; Consortium for the Study of Chronic Pancreatitis; Diabetes; and Pancreatic
Cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet
Gastroenterol Hepatol 2016;1:226-37. DOI PubMed PMC
30. Lernmark A, Freedman ZR, Hofmann C, et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 1978;299:375-
80. DOI